TABLE 4.
Fasting biochemical characteristics of the subjects (n = 30) at the end of each diet1
| SFA diet | ω-6 PUFA diet | %Δ | P 2 | |
|---|---|---|---|---|
| ApoA-V, ng/mL | 58.2 ± 34.9 | 48.6 ± 21.1 | –16.5 ± 12.8 | 0.1 |
| ApoC-II, μg/mL | 149 ± 48 | 155 ± 54 | +4.0 ± 8.8 | 0.5 |
| ApoC-III, μg/mL | 144 ± 69 | 134 ± 54 | –6.9 ± 11.1 | 0.5 |
| ApoE, μg/mL | 37.5 ± 11.5 | 35.6 ± 8.3 | –5.2 ± 6.9 | 0.2 |
| CETP, ng/mL | 2089 ± 406 | 1999 ± 379 | –4.3 ± 4.8 | 0.2 |
| HL, ρg/mL | 7907 ± 1312 | 8178 ± 1354 | +3.4 ± 4.4 | 0.4 |
| LPL, ng/mL | 3899 ± 8943 | 3963 ± 9100 | +1.6 ± 59.7 | 0.6 |
| ANGPTL3, ng/mL | 130 ± 31 | 130 ± 33 | 0.0 ± 6.37 | 0.9 |
| LDLR, ng/mL | 61.2 ± 22.9 | 62.3 ± 17.6 | +1.7 ± 8.6 | 0.3 |
| Glucose, mmol/L | 5.25 ± 0.61 | 5.21 ± 0.69 | –0.8 ± 3.2 | 0.6 |
| Insulin, ρmol/L | 129 ± 41 | 133 ± 36 | +3.1 ± 7.8 | 0.3 |
| HOMA-IR index | 4.37 ± 1.56 | 4.43 ± 1.29 | +1.4 ± 8.5 | 0.5 |
| CRP, mg/L | 7.72 ± 15.92 | 5.87 ± 4.87 | –24.0 ± 39.4 | 0.2 |
| TC, mmol/L | 4.91 ± 0.83 | 4.67 ± 0.86 | –4.9 ± 4.5 | 0.3 |
| TG, mmol/L | 2.02 ± 0.91 | 1.86 ± 0.77 | –7.9 ± 10.9 | 0.9 |
| HDL-C, mmol/L | 1.02 ± 0.21 | 1.00 ± 0.17 | –2.0 ± 4.9 | 0.9 |
| LDL-C, mmol/L | 2.96 ± 0.68 | 2.79 ± 0.73 | –5.7 ± 6.4 | 0.06 |
| Non HDL-C, mmol/L | 3.90 ± 0.82 | 3.67 ± 0.84 | –5.9 ± 5.4 | 0.4 |
| TC/HDL-C | 5.01 ± 1.23 | 4.78 ± 1.15 | –4.4 ± 6.2 | 0.8 |
1
Diet-specific data are presented as means ± SDs. Differences between diets are presented as means ± SEMs. Apo, apolipoprotein; ANGPTL3, angiopoietin-like 3; CETP, cholesteryl ester transfer protein; CRP, C-reactive protein; HDL-C, HDL cholesterol; HL, hepatic lipase; LDL-C, LDL cholesterol; LDLR, LDL receptor; LPL, lipoprotein lipase; TC, total cholesterol; TG, triglyceride; Δ, change.
2
P values were calculated with mixed models for repeated measures with subjects as a random effect.